Supriya Lifescience Ltd Cash Flow Statement: Consolidated Financial Analysis & Historical Data (15 Years)

Cash Flow

Supriya Lifesci. Cash flow Statement

Figures in Cr

Standaloned Cash Flow Results

Mar'26

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Figures in INR Cr
Seasonal companies are compared with the same quarter last year

Compare Cash Flow Results of Supriya Lifesci.

Select Peers

Figures in Cr

standaloned Cash Flow Results

Change(INR)

Change(%)

Profit Before Tax

274.78

444.7

-170.00

-38.21%

Adjustment

19.89

28.8

-9.00

-30.94%

Changes In working Capital

-47.5

71.6

-118.00

-166.34%

Cash Flow after changes in Working Capital

247.17

545.1

-298.00

-54.66%

Cash Flow from Operating Activities

185.77

438.3

-253.00

-57.62%

Cash Flow from Investing Activities

-176.17

-11.3

-165.00

-1459.03%

Cash Flow from Financing Activities

-9.88

-447.9

438.00

97.79%

Net Cash Inflow / Outflow

-0.29

-20.9

20.00

98.61%

Opening Cash & Cash Equivalents

79.15

283.8

-204.00

-72.11%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

0.00

0.00%

Closing Cash & Cash Equivalent

78.87

262.9

-184.00

-70.00%

Cash Flow - Snapshot (Standalone) - Mar'26

YoY Growth in year ended Mar 2026 is 12.81% vs 45.34% in Mar 2025

Mar'26

Mar'25

Change(%)

Cash Flow from Operating Activities

185.77

164.68

12.81%